Get the Stockscreener App
26.93
1.05%
0.28
Assembly Biosciences Inc stock is traded at $26.93, with a volume of 101.41K.
It is up +1.05% in the last 24 hours and up +44.16% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$26.65
Open:
$26.64
24h Volume:
101.41K
Relative Volume:
1.92
Market Cap:
$206.61M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-1.992
EPS:
-13.5194
Net Cash Flow:
$22.49M
1W Performance:
+5.86%
1M Performance:
+44.16%
6M Performance:
+118.06%
1Y Performance:
+86.88%
1-Day Range:
$26.50
$27.17
1-Week Range:
$24.80
$27.17
52-Week Range:
$7.75
$27.17
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
26.93 | 197.64M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
Short Interest Drops in Assembly Biosciences Inc. After RallyMarket Risk Report & Breakout Confirmation Alerts - newsyoung.net
What candlestick patterns are forming on Assembly Biosciences Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - Newser
Analyzing drawdowns of Assembly Biosciences Inc. with statistical tools2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Is Assembly Biosciences Inc. reversing from oversold territoryRate Hike & Fast Entry Momentum Trade Alerts - Newser
Analyzing recovery setups for Assembly Biosciences Inc. investorsJuly 2025 EndofMonth & Pattern Based Trade Signal System - Newser
Volatility clustering patterns for Assembly Biosciences Inc.2025 Winners & Losers & Precise Trade Entry Recommendations - Newser
Intraday pattern recognizer results for Assembly Biosciences Inc.Weekly Market Summary & Fast Momentum Stock Entry Tips - Newser
How institutional ownership impacts Assembly Biosciences Inc. stock2025 Market Overview & Trade Opportunity Analysis - Newser
Using AI based signals to follow Assembly Biosciences Inc.Weekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
How to use a screener to detect Assembly Biosciences Inc. breakoutsMarket Rally & High Yield Equity Trading Tips - Newser
Published on: 2025-08-19 16:37:07 - Newser
Relative strength of Assembly Biosciences Inc. in sector analysisJuly 2025 Breakouts & Safe Capital Growth Tips - Newser
HC Wainwright Initiates Coverage on Assembly Biosciences (NASDAQ:ASMB) - Defense World
Assembly Biosciences Inc. stock trend forecastTrade Signal Summary & Daily Technical Forecast Reports - Newser
How Resilient Is Assembly Biosciences Inc. Stock During Economic DownturnsForecast Cut & Advanced Swing Trade Entry Plans - Newser
Assembly Biosciences Inc. stock volume spike explainedTrade Entry Summary & Advanced Swing Trade Entry Plans - Newser
Assembly Biosciences (NASDAQ:ASMB) Coverage Initiated by Analysts at HC Wainwright - Defense World
Automated trading signals detected on Assembly Biosciences Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Assembly Biosciences Gains Buy Rating from H.C. Wainwright with $50 Price Target - AInvest
Assembly Biosciences stock receives Buy rating from H.C. Wainwright By Investing.com - Investing.com Nigeria
Assembly Biosciences stock receives Buy rating from H.C. Wainwright - Investing.com
Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement - Mintz
Assembly Biosciences: HC Wainwright assumes Buy rating, $50 PT. - AInvest
Applying Wyckoff theory to Assembly Biosciences Inc. stock2025 Short Interest & Daily Profit Focused Screening - Newser
Sector ETF performance correlation with Assembly Biosciences Inc.Quarterly Profit Summary & Weekly Top Performers Watchlists - Newser
Is Assembly Biosciences Inc. stock poised for growthJuly 2025 Big Picture & Technical Buy Zone Confirmations - Newser
Can you recover from losses in Assembly Biosciences Inc.Rate Hike & Low Drawdown Investment Strategies - Newser
Resistance Break Could Fuel Assembly Biosciences Inc. RallyMarket Movers & Target Return Focused Stock Picks - beatles.ru
Is a relief rally coming for Assembly Biosciences Inc. holders2025 Technical Overview & Stepwise Trade Signal Implementation - Newser
Is Now a Good Time to Reenter Assembly Biosciences Inc.July 2025 Outlook & Safe Entry Trade Reports - newsyoung.net
When is the best time to exit Assembly Biosciences Inc.2025 Key Lessons & Free Reliable Trade Execution Plans - Newser
Analyzing net buyer seller activity in Assembly Biosciences Inc.Weekly Trend Report & AI Enhanced Execution Alerts - Newser
Long term hold vs stop loss in Assembly Biosciences Inc.Quarterly Portfolio Review & Entry Point Confirmation Signals - Newser
Historical volatility pattern of Assembly Biosciences Inc. visualizedEarnings Summary Report & AI Enhanced Trading Alerts - Newser
Assembly Biosciences Inc. stock outlook for YEAREarnings Risk Report & Detailed Earnings Play Alerts - Newser
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assembly Biosciences Inc Stock (ASMB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Principal Accounting Officer |
Mar 31 '25 |
Sale |
9.85 |
180 |
1,773 |
4,617 |
| Okazaki Jason A | CEO and President |
Mar 31 '25 |
Sale |
9.85 |
355 |
3,496 |
14,757 |
| White Nicole S | Chief Manufacturing Officer |
Mar 31 '25 |
Sale |
9.85 |
197 |
1,940 |
11,674 |
| Houghton Michael | Director |
Dec 30 '24 |
Buy |
15.61 |
3,202 |
49,998 |
3,202 |
| GILEAD SCIENCES, INC. | 10% Owner |
Dec 19 '24 |
Buy |
21.37 |
940,499 |
20,098,464 |
2,209,471 |
| Schornstein Alexander | 10% Owner |
Nov 22 '24 |
Buy |
14.87 |
17,024 |
253,104 |
720,137 |
| Schornstein Alexander | 10% Owner |
Nov 25 '24 |
Buy |
14.91 |
7,976 |
118,890 |
728,113 |
| White Nicole S | Chief Manufacturing Officer |
Nov 18 '24 |
Sale |
16.29 |
40 |
652 |
11,871 |
| Schornstein Alexander | 10% Owner |
Oct 08 '24 |
Buy |
14.58 |
10,000 |
145,800 |
703,113 |
| White Nicole S | Chief Manufacturing Officer |
Oct 03 '24 |
Sale |
14.81 |
157 |
2,325 |
11,911 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):